<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12">
 <label>12.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Dans</surname>
    <given-names>AL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dans</surname>
    <given-names>LF</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lansang</surname>
    <given-names>MAD</given-names>
   </name>, 
   <name name-style="western">
    <surname>Silvestre</surname>
    <given-names>MAA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Guyatt</surname>
    <given-names>GH</given-names>
   </name>
  </person-group>
  <year>2018</year>
  <article-title>Controversy and debate on dengue vaccine series—paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs</article-title>. 
  <source>J Clin Epidemiol</source>
  <volume>95</volume>:
  <fpage>137</fpage>–
  <lpage>139</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.jclinepi.2017.11.019</pub-id>.
  <pub-id pub-id-type="pmid">29180056</pub-id>
 </mixed-citation>
</ref>
